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Coronary artery disease is a common malady in Western
civilizations [1]. Coronary interventions have increased in
frequency, improving the quality of life for many coronary
artery disease patients. In fact, it is estimated that more than
one million procedures occur each year [2]. Although
complications in the coronary artery can be devastating,
peripheral complications are also of concern. These
procedures involve arterial puncture with a relatively large
bore cannula, and hematoma formation, pseudoaneurysms
and other local complications are not infrequent [3,4].
Following percutaneous coronary interventions for acute and
chronic coronary syndromes, manual compression of the
femoral access site has been standard management. Arterial
puncture-closing devices (APCDs) have been developed
over the past three decades with the hope of avoiding
manual compression and of shortening the period of bed rest
prescribed after a percutaneous coronary intervention.
In a recent publication in the Journal of the American
Medical Association, Koreny and colleagues present a
systematic review and meta-analysis of APCDs compared
with standard manual compression [5]. They searched
several literature databases and queried experts and
manufacturers for clinical trials comparing these methods of
maintaining hemostasis. Thirty randomized trials eventually
met the authors’ selection criteria. The reviewers then
abstracted the data, and random effects models were
constructed to pool the data for meta-analysis. Koreny and
colleagues report relative risks for growing hematoma,
bleeding, development of arteriovenous fistula and
psudoaneurysm at the puncture site, which were not
significantly different between APCDs and manual
compression. However, the confidence intervals for these
relative risks were quite wide in their meta-analysis.
A meta-analysis is an attempt to combine data from several
separate primary data sources to increase the power for the
study for the outcome variable. Meta-analyses are dependent
on the quality of the original studies and on the reports of
those studies. As Koreny and colleagues note, the quality of
the reports for the studies included in their systematic review
was generally only fair. Blinded outcome assessment,
allocation concealment and explicit intention-to-treat reporting
were not common among these selected studies. It is also
important to note that 12 of the 30 selected reports were only
in abstract form. These studies reported both diagnostic and
therapeutic procedures, and they used several different
APCDs. The definitions of the outcome variables are also an
important consideration in a meta-analysis and, in fact, some
of the studies included in this systematic analysis do not even
define some of the outcome variables.
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Abstract
Coronary artery disease remains a common problem in industrialized countries. Percutaneous coronary
interventions are usually performed utilizing the femoral approach. Arterial puncture-closing devices
have been developed in hope to avoid manual compression and shortening the period of rest. In a
recent meta-analysis in the Journal of the American Medical Association these devices have shown
only marginal benefits over manual compression. Further, well designed studies are necessary to
document the comparative effects of these devices versus manual compression.
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The conclusions of Koreny and colleagues is that there is
only marginal evidence that APCDs are effective. Given the
poor quality of the reported clinical data and the
heterogeneity evident in the data, one cannot make any other
conclusion. The question to us remains ‘to plug or not to
plug?’, and the answer requires well-designed, randomized,
blinded clinical trials.
Hemostatic occlusion of a puncture vessel is an important
issue for clinicians caring for patients that have undergone
any kind of large-caliber arterial puncture, including
interventional radiologists, diagnostic cardiologists and critical
care practitioners. Before adopting new hemostatic
techniques or devices, should not solid evidence of
comparative efficacy be available? At the current time, the
clinician faced with the question of APCDs or not has little
information with which to guide a rationale decision. As
Koreny and colleagues noted, if one limits the analysis to
clinical trials in which explicit intention-to-treat approaches
were used, APCDs appeared to increase the risk of
hematoma and psudoaneurysm, with 95% confidence limits
that do not include unity. We must agree with the authors of
this meta-analysis that further study is necessary documenting
the comparative efficacy of APCDs.
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